Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Active immunotherapy with B.C.G. for recurrent malignant melanoma.

Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet. 1973 Jun 02; 1(7814):1208-12.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.